(Q53482911)

14 May 2018

title

Optimized curcumin formulations for the treatment of Alzheimer's disease: A patent evaluation. (English)

1 reference

14 May 2018

0 references

1 reference

2

Amirhossein Sahebkar

1 reference

14 May 2018

Abolfazl Shakeri

1

1 reference

14 May 2018

publication date

17 November 2015

1 reference

14 May 2018

Journal of Neuroscience Research

published in

1 reference

14 May 2018

volume

94

1 reference

14 May 2018

issue

2

1 reference

14 May 2018

page(s)

111-113

1 reference

14 May 2018

Acetylcholinesterase inhibitors: pharmacology and toxicology

cites work

1 reference

Neuroprotective effect of natural products against Alzheimer's disease.

21 January 2018

1 reference

Enhancement of Oral Bioavailability of Curcumin by a Novel Solid Dispersion System

21 January 2018

1 reference

Effects of naturally occurring compounds on fibril formation and oxidative stress of beta-amyloid

21 January 2018

1 reference

Quantitative proteomics reveals that PEA15 regulates astroglial Aβ phagocytosis in an Alzheimer's disease mouse model.

21 January 2018

1 reference

Curcumin suppresses soluble tau dimers and corrects molecular chaperone, synaptic, and behavioral deficits in aged human tau transgenic mice

21 January 2018

1 reference

Alzheimer's disease-do tauists and baptists finally shake hands?

21 January 2018

1 reference

Antioxidant and anti-inflammatory effects of curcuminoid-piperine combination in subjects with metabolic syndrome: A randomized controlled trial and an updated meta-analysis

21 January 2018

1 reference

Investigation of the efficacy of adjunctive therapy with bioavailability-boosted curcuminoids in major depressive disorder

21 January 2018

1 reference

Adjuvant therapy with bioavailability-boosted curcuminoids suppresses systemic inflammation and improves quality of life in patients with solid tumors: a randomized double-blind placebo-controlled trial

21 January 2018

1 reference

Lipid-modifying effects of adjunctive therapy with curcuminoids-piperine combination in patients with metabolic syndrome: results of a randomized controlled trial.

21 January 2018

1 reference

Curcuminoid treatment for knee osteoarthritis: a randomized double-blind placebo-controlled trial.

21 January 2018

1 reference

Molecular mechanisms for curcumin benefits against ischemic injury

21 January 2018

1 reference

Why it is necessary to translate curcumin into clinical practice for the prevention and treatment of metabolic syndrome?

21 January 2018

1 reference

Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? Evidence from a meta-analysis

21 January 2018

1 reference

Curcuminoids modulate pro-oxidant-antioxidant balance but not the immune response to heat shock protein 27 and oxidized LDL in obese individuals

21 January 2018

1 reference

Recent advances in pharmacotherapy for hypertriglyceridemia

21 January 2018

1 reference

Non-apolipoprotein E and apolipoprotein E genetics of sporadic Alzheimer's disease

21 January 2018

1 reference

Alzheimer's disease, enzyme targets and drug discovery struggles: from natural products to drug prototypes

21 January 2018

1 reference

Role of oxidative stress in the progression of Alzheimer's disease

21 January 2018

1 reference

Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo

21 January 2018

1 reference

The effect of curcumin on the stability of Aβ dimers

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JNR.23696

1 reference

14 May 2018

1 reference

14 May 2018